TAVI sessions from EuroPCR 2025 : Abbott

Sponsored by Abbott

TAVI session from EuroPCR 2025

Optimising self-expandable TAVI clinical outcomes without compromise

Discussants: M. Adamo, L. Conradi, N. Dumonteil, J. Kefer, I. Malik, T. Pilgrim, S. Redwood

TAVI session from PCR London Valves 2024

Pushing the boundaries to optimise patient outcomes: from planning to success

Discussants: M. Akodad, O. De Backer, R. Dworakowski, H. Möllmann, T. Patterson, L. Testa, T. Walther

TAVI sessions from EuroPCR 2024

Case closed: understanding the steps of vascular access and closure in TAVI patients

Discussants: O. De Backer, D. Milasinovic, M. Taramasso, W. Voelker

Contemporary TAVI: the VISION of lifetime management

Discussants: O. De Backer, C. De Biase, D. Mylotte, F. Sawaya, M. Taramasso, G. Tang

TAVI session from PCR London Valves 2023

Best contemporary clinical practice for TAVI

Discussants: M. Abdel-Wahab, H. Dreger, C. Gandolfo, K. Hayashida, A. Neylon, P. Pibarot, M. Taramasso, P. Pibarot

Related links

Five-year durability analysis of an intra-annular self-expandable transcatheter aortic bioprosthesis

Supra- vs. intra-annular self-expanding trancatheter heart valve in valve-in-valve procedures

Consult abstract

TAVI sessions from EuroPCR 2023

Defining together the ideal TAVI platform of the future

Discussants: F. Maisano, P. Jimenez Quevedo, J. Kempfert, M. Leon, M. Van Wely, F. Bedogni, F. De Marco, D. Dvir, G. Fontana, T. Patterson

The importance of optimal vascular access and closure in TAVI patients

Discussants: F. Maisano, M. Taramasso, S. Berti, O. De Backer

TAVI session from PCR London Valves 2022

Haemodynamic performance of transcatheter aortic valves: practical considerations for lifetime management

Discussants: L. Conradi, D. Dvir, W.-K. Kim, F. Nietlispach, D. Smith, L. Testa

Related link

Paravalvular leak and haemodynamics by valve size for the Navitor transcatheter aortic heart valve

Page published on May 2023